The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Safety assessment of niraparib individualized starting dose in patients with platinum-sensitive recurrent ovarian cancer: A randomized, double-blind, placebo-controlled, phase III NORA trial.
 
Jing Wang
No Relationships to Disclose
 
Xiaohua Wu
No Relationships to Disclose
 
Jianqing Zhu
No Relationships to Disclose
 
Rutie Yin
No Relationships to Disclose
 
Jiaxin Yang
No Relationships to Disclose
 
Qidan Huang
No Relationships to Disclose
 
Lingying Wu
No Relationships to Disclose
 
Ziling Liu
No Relationships to Disclose
 
Yunong Gao
No Relationships to Disclose
 
Danbo Wang
No Relationships to Disclose
 
Ge Lou
No Relationships to Disclose
 
Hongying Yang
No Relationships to Disclose
 
Qi Zhou
No Relationships to Disclose
 
Beihua Kong
No Relationships to Disclose
 
Yi Huang
No Relationships to Disclose
 
Lipai Chen
No Relationships to Disclose
 
Guiling Li
No Relationships to Disclose
 
Ruifang An
No Relationships to Disclose
 
Tao Tan
Employment - Zai Lab
 
Juan Dong
Employment - Zai Lab